Muscle and Bone Health in Young Chilean Adults with Phenylketonuria and Different Degrees of Compliance with the Phenylalanine Restricted Diet

Nutrients. 2023 Jun 28;15(13):2939. doi: 10.3390/nu15132939.

Abstract

There are concerns about muscle and bone health in patients with Phenylketonuria (PKU). Our aim was to compare muscle mass, function, and bone health among young adults with PKU who maintained or suspended dietary treatment.

Methods: Three groups were considered-PKU-1: 10 patients who used a protein substitute (PS) without phenylalanine (Phe); PKU-2: 14 patients who used the PS without Phe until eighteen years old and then practiced mostly a vegan diet; and 24 matched healthy controls. A 24 h recall survey, blood parameters, body composition and bone mineral density through DEXA, rectus femoris thickness by ultrasound, hand grip strength, submaximal exercise test, and walking speed were assessed.

Results: PKU-1 patients had lower hand grip strength than their matched controls, but no other differences. Compared to controls, the PKU-2 group had lower fat-free mass (p = 0.01), less spine and femoral bone mineral density (p = 0.04 and p < 0.01, respectively), and peak workload on the incremental test (p = 0.03). When comparing PKU groups, blood Phe levels were significantly lower in the PKU-1 group (p = 0.02).

Conclusions: Among PKU patients, abandoning the dietary treatment and maintaining high blood Phe concentrations could be deleterious for muscles and bones. However, we cannot discard other causes of bone and muscle damage in these patients.

Keywords: inborn error of metabolism; muscle function; muscle mass; phenylalanine.

MeSH terms

  • Adolescent
  • Bone Density
  • Chile
  • Diet
  • Hand Strength
  • Humans
  • Muscles / metabolism
  • Phenylalanine*
  • Phenylketonurias*
  • Young Adult

Substances

  • Phenylalanine

Grants and funding

This study was not financed by any grant. This study was supported by the Laboratory of Genetic and Metabolic Diseases (LabGEM), INTA, University of Chile.